NewGLAB Pharma CO.,LTD

KOSDAQ:A214870 Stock Report

Market Cap: ₩45.8b

NewGLAB PharmaLTD Past Earnings Performance

Past criteria checks 0/6

NewGLAB PharmaLTD's earnings have been declining at an average annual rate of -49.4%, while the Electronic industry saw earnings growing at 21.6% annually. Revenues have been declining at an average rate of 6.7% per year.

Key information

-49.4%

Earnings growth rate

-36.1%

EPS growth rate

Electronic Industry Growth21.6%
Revenue growth rate-6.7%
Return on equityn/a
Net Margin-394.1%
Last Earnings Update31 Mar 2023

Recent past performance updates

Recent updates

The NewGLABLTD (KOSDAQ:214870) Share Price Has Gained 274%, So Why Not Pay It Some Attention?

Dec 22
The NewGLABLTD (KOSDAQ:214870) Share Price Has Gained 274%, So Why Not Pay It Some Attention?

Revenue & Expenses Breakdown

How NewGLAB PharmaLTD makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

KOSDAQ:A214870 Revenue, expenses and earnings (KRW Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 2318,570-73,18449,65511,623
31 Dec 2221,711-69,55050,96610,998
30 Sep 2226,580-45,90117,30410,627
30 Jun 2225,591-50,42517,18411,151
31 Mar 2227,622-52,11118,0909,938
31 Dec 2129,354-50,51117,77011,294
30 Sep 2139,352-30,94216,07010,974
30 Jun 2142,239-29,21816,01110,035
31 Mar 2148,287-24,83414,97510,640
31 Dec 2054,417-22,60916,6177,798
30 Sep 2064,026-12,46817,5325,651
30 Jun 2071,391-8,68919,2844,901
31 Mar 2088,649-7,24523,3582,448
31 Dec 1995,820-4,00623,8051,928
30 Sep 1973,253-9,61120,9301,728
30 Jun 1961,783-10,29316,1321,183
31 Mar 1935,647-4,9768,6221,277
31 Dec 1818,640-7,3623,9561,338
30 Sep 1819,873-9,3514,4801,520
30 Jun 1820,566-9,3855,4841,219
31 Mar 1825,389-10,1025,2451,726
31 Dec 1730,603-9,1155,2751,707
30 Sep 1735,184-3,5373,4691,644
31 Dec 1632,877-1,0893,1081,332

Quality Earnings: A214870 is currently unprofitable.

Growing Profit Margin: A214870 is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: A214870 is unprofitable, and losses have increased over the past 5 years at a rate of 49.4% per year.

Accelerating Growth: Unable to compare A214870's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: A214870 is unprofitable, making it difficult to compare its past year earnings growth to the Electronic industry (-38.1%).

Return on Equity

High ROE: A214870's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/06/06 19:01
End of Day Share Price 2023/03/09 00:00
Earnings2023/03/31
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

NewGLAB Pharma CO.,LTD is covered by 1 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jongsun ParkEugene Investment & Securities Co Ltd.